Ladenburg Thalmann Financial Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 4806 |
|
2019
Q3 | $1K | Hold |
150
| – | – | ﹤0.01% | 5175 |
|
2019
Q2 | $2K | Hold |
150
| – | – | ﹤0.01% | 5017 |
|
2019
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 4980 |
|
2018
Q4 | $2K | Hold |
150
| – | – | ﹤0.01% | 4942 |
|
2018
Q3 | $3K | Hold |
150
| – | – | ﹤0.01% | 4805 |
|
2018
Q2 | $3K | Hold |
150
| – | – | ﹤0.01% | 4794 |
|
2018
Q1 | $3K | Hold |
150
| – | – | ﹤0.01% | 4794 |
|
2017
Q4 | $2K | Hold |
150
| – | – | ﹤0.01% | 4813 |
|
2017
Q3 | $2K | Hold |
150
| – | – | ﹤0.01% | 4705 |
|
2017
Q2 | $2K | Hold |
150
| – | – | ﹤0.01% | 4629 |
|
2017
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 4604 |
|
2016
Q4 | $2K | Hold |
150
| – | – | ﹤0.01% | 4561 |
|
2016
Q3 | $2K | Hold |
150
| – | – | ﹤0.01% | 4521 |
|
2016
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 4065 |
|
2016
Q1 | $4K | Hold |
150
| – | – | ﹤0.01% | 4182 |
|
2015
Q4 | $8K | Hold |
150
| – | – | ﹤0.01% | 3824 |
|
2015
Q3 | $6K | Buy |
+150
| New | +$6K | ﹤0.01% | 3862 |
|